Marijuana Company of America, Inc. to Present at LD Micro Invitational XII Conference on June 8, 2022
LOS ANGELES, CA / ACCESSWIRE / June 1, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), operates,...
Day: June 1, 2022
Moderna to Present at Upcoming Conferences in June 2022
CAMBRIDGE, MA / ACCESSWIRE / June 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent GlioblastomaABINGDON, OXFORDSHIRE / ACCESSWIRE / June 1, 2022...
Privia Health to Participate in Upcoming Investor Conferences
ARLINGTON, Va., June 01, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), today announced that its management team...
Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System
Featured Image for Royal Biologics Featured Image for Royal BiologicsHACKENSACK, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Royal Biologics (Hackensack,...
ResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief...
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. and Levena Biopharma, a Sorrento Company, are to Present Positive Clinical Progress of A166, an Anti-HER2 ADC, in Treating Locally Advanced or Metastatic HER2-Positive Breast Cancer Patients at the ASCO 2022 Annual Meeting
A166 is an antibody-drug conjugate (ADC) composed of an anti-HER2 antibody conjugated to Duostatin-5, a novel anti-microtubule Auristatin derivative, via...
Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug
Irvine, CA, June 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a...
Chiesi USA Announces First Analysis from the CAMEO Registry Assessing KENGREAL® (cangrelor) Use and Transition to Oral P2Y12 Inhibitors in Routine Clinical Practice
The CAMEO registry, an ongoing study to provide real-world data on KENGREAL® (cangrelor), has published interim results in the Journal...
TransCode Therapeutics Receives National Institutes of Health (NIH) Notice of Award
Funding is part of a 2021 Fast-Track Small Business Innovation Research (SBIR) grant to Support Clinical Development of First-in-Class Therapy...
Kymera Therapeutics Receives FDA Orphan Drug Designation for KT-333, a First-in-Class, Investigational STAT3 Degrader for the Treatment of Peripheral T-Cell Lymphoma
WATERTOWN, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein...
Healthy Extracts Major Brand Influencer Launches the World’s First Brain Activate Gel Packs on WhitneyJohns.com
Brain Activate EEG Scans Images from EEG scans following the consumption of the company's active ingredients. Orange and red indicate...
Artelo Biosciences to Present at the LD Micro Invitational XII on June 7th
SOLANA BEACH, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical-stage...
Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing...
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Alaunos Therapeutics to Present at the Jefferies Healthcare Conference
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell...
Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification
NEW YORK and SYDNEY, June 01, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical...
Streamline Health® To Report First Quarter 2022 Financial Performance and Provide Corporate Update
Atlanta, GA, June 01, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading...
Assertio Holdings, Inc. to Participate in LD Micro Invitational XII Conference
LAKE FOREST, Ill., June 01, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty...
Pardes Biosciences to Present at Jefferies Global Healthcare Conference
CARLSBAD, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as...